CIK 0001604191 · Non-accelerated filer<br>Smaller reporting company
GridAI Technologies Corp.
Sign in to watch- Ticker
- GRDX
- Exchange
- Nasdaq
- Industry
- Electric & Other Services Combined
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464993860
- Phone
- 561-589-7020
- Business address
- 433 PLAZA REAL, SUITE 275, BOCA RATON, FL
- Former names
- Entero Therapeutics, Inc., First Wave BioPharma, Inc., AzurRx BioPharma, Inc., BioPharma d'Azur, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-02 | Romano Sarah Chief Financial Officer | Sale | −621 | $1.07 | $664 | 18,490 |
| 2024-07-02 | SAPIRSTEIN JAMES Chairman and CEO | Sale | −1,289 | $1.07 | $1K | 35,816 |
| 2024-06-11 | KHOSLA CHAITAN PHD Director | Grant or award | +24,889 | 24,889 | ||
| 2024-04-01 | SAPIRSTEIN JAMES Chairman and CEO | Sale | −174 | $4.23 | $736 | 37,105 |
| 2024-04-01 | Romano Sarah Chief Financial Officer | Sale | −75 | $4.23 | $317 | 19,111 |
| 2024-03-15 | SAPIRSTEIN JAMES Chairman and CEO | Sale | −1,887 | $4.96 | $9K | 37,279 |
| 2024-03-15 | Romano Sarah Chief Financial Officer | Sale | −1,120 | $4.96 | $6K | 19,186 |
| 2024-03-13 | Syage Jack President & COO | Grant or award | +15,400 | 15,400 | ||
| 2024-03-13 | Syage Jack President & COO | Grant or award · Series G Non-Voting Convertible Preferred Stock | +4,920.04 | 4,920.04 | ||
| 2024-03-13 | KHOSLA CHAITAN PHD Director | Grant or award | +440 | 440 | ||
| 2024-03-13 | KHOSLA CHAITAN PHD Director | Grant or award · Series G Non-Voting Convertible Preferred Stock | +140.7 | 140.7 | ||
| 2024-03-13 | KHOSLA CHAITAN PHD Director | Grant or award · Stock Option (right to buy) | +52,980 | 52,980 | ||
| 2024-01-12 | Romano Sarah Chief Financial Officer | Sale | −98 | $4.20 | $412 | 20,306 |
| 2024-01-12 | SAPIRSTEIN JAMES Chairman, President and CEO | Sale | −166 | $4.20 | $697 | 39,166 |
| 2024-01-02 | CASAMENTO CHARLES J Director | Grant or award | +19,633 | 19,937 | ||
| 2024-01-02 | Riddell Alastair Director | Grant or award | +19,633 | 20,240 | ||
| 2024-01-02 | Coelho Mary Theresa Director | Grant or award | +19,633 | 20,237 | ||
| 2024-01-02 | BORKOWSKI EDWARD Director | Grant or award | +19,633 | 20,248 | ||
| 2024-01-02 | SAPIRSTEIN JAMES Chairman, President and CEO | Grant or award | +20,000 | 39,332 | ||
| 2024-01-02 | Romano Sarah Chief Financial Officer | Grant or award | +7,000 | 20,404 |
Page 2 of 7 · 136 trades